Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Incyte Corporation - Common Stock (NQ:INCY)

129.72 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 25, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	151
Open	129.72
Bid (Size)	125.09 (100)
Ask (Size)	132.28 (100)
Prev. Close	129.72
Today's Range	129.72 - 129.72
52wk Range	81.09 - 132.60
Shares Outstanding	222,430,635
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Here’s How Much You Would Have Made Owning Incyte Stock In The Last 20 Years ↗

August 20, 2026

Incyte (NASDAQ:INCY) has outperformed the market over the past 20 years by 8.29% on an annualized basis producing an average annual return of 17.52%. Currently, Incyte has a market capitalization of...

Via Benzinga

Incyte (NASDAQ:INCY) Combines High Growth Momentum with a Breakout Setup ↗

August 17, 2026

Via Chartmill

Performance

YTD	+27.9%	+27.9%
1 Month	+9.1%	+9.1%
3 Month	+33.6%	+33.6%
6 Month	+28.4%	+28.4%
1 Year	+53.0%	+53.0%

More News

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 07, 2026

From Incyte Corporation

Via Business Wire

July 31, 2026

Via StockStory

Opzelura® (ruxolitinib) Cream Becomes First Steroid-Free Topical JAK Inhibitor Approved in the European Union for Adults with Moderate Atopic Dermatitis

July 29, 2026

From Incyte

Via Business Wire

Incyte (NASDAQ:INCY): High Growth Stock Slides on Q2 Beat but Steep Guidance Cut ↗

July 28, 2026

Via Chartmill

INCYTE CORP (NASDAQ:INCY) Exhibits Perfect Technical Breakout Setup with Strong Ratings ↗

July 27, 2026

Via Chartmill

INCYTE CORP (NASDAQ:INCY) Screens as a High Growth Momentum Stock with a Breakout Setup ↗

July 24, 2026

Via Chartmill

Exploring the top movers within the S&P500 index during today's session. ↗

July 28, 2026

Via Chartmill

Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below. ↗

July 28, 2026

Via Chartmill

Incyte Q2 Earnings Call Highlights ↗

July 28, 2026

Via MarketBeat

Incyte (NASDAQ:INCY) Posts Better-Than-Expected Sales In Q2 CY2026 But Full-Year Sales Guidance Misses Expectations Significantly

July 28, 2026

Via StockStory

Incyte Corp (NASDAQ:INCY) Shows Value Stock Strength With Strong Fundamentals and Low Valuation ↗

July 20, 2026

Via Chartmill

Incyte Reports Second Quarter 2026 Financial Results and Provides Business Updates

July 28, 2026

From Incyte

Via Business Wire

What To Expect From Incyte’s (INCY) Q2 Earnings

July 26, 2026

Via StockStory

Incyte Data to Be Highlighted in Four Rapid Oral Presentations at the European Society for Medical Oncology (ESMO) Congress 2026 Support Efforts to Improve Outcomes in Difficult-to-Treat Cancers

July 17, 2026

From Incyte

Via Business Wire

Incyte (INCY): Buy, Sell, or Hold Post Q1 Earnings?

July 15, 2026

Via StockStory

Incyte Presents Phase 1/2 Multidose Data for VGA039 (Latarcibart) at ISTH 2026, Showing Substantial Bleed Reductions in Patients with all Von Willebrand Disease Types

July 13, 2026

From Incyte

Via Business Wire

Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks

July 12, 2026

Via StockStory

2 Fast-Growing Pharmaceutical Stocks to Buy Now ↗

July 08, 2026

Via The Motley Fool

Incyte to Report Second Quarter Financial Results

July 08, 2026

From Incyte

Via Business Wire

Incyte Completes Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio

July 06, 2026

From Incyte

Via Business Wire

1 Mid-Cap Stock to Research Further and 2 We Avoid

July 03, 2026

Via StockStory

Hormuz Goes Quiet, Software Wakes Up, and Burry Picks a Side ↗

June 29, 2026

Via Chartmill

1 Cash-Producing Stock with Solid Fundamentals and 2 We Turn Down

June 29, 2026

Via StockStory

Frequently Asked Questions

Is Incyte Corporation - Common Stock publicly traded?

Yes, Incyte Corporation - Common Stock is publicly traded.

What exchange does Incyte Corporation - Common Stock trade on?

Incyte Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Incyte Corporation - Common Stock?

The ticker symbol for Incyte Corporation - Common Stock is INCY on the Nasdaq Stock Market

What is the current price of Incyte Corporation - Common Stock?

The current price of Incyte Corporation - Common Stock is 129.72

When was Incyte Corporation - Common Stock last traded?

The last trade of Incyte Corporation - Common Stock was at 08/25/26 04:00 PM ET

What is the market capitalization of Incyte Corporation - Common Stock?

The market capitalization of Incyte Corporation - Common Stock is 28.85B

How many shares of Incyte Corporation - Common Stock are outstanding?

Incyte Corporation - Common Stock has 29B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.